Medical News

RSS

Local anesthetics have potential therapeutic effects on IBD: Research article

Inflammatory bowel disease is a disease of the gastrointestinal tract, mainly the intestines that may occur in the people who have genetic potential with a contribution of environmental factors. There has been no definitive medical treatment and drugs usually help the symptoms just to relieve.

8 Jul 2010

Medizone seeks international patent protection for Asepticsure technology

Medizone International, Inc. has filed an international patent application under the auspices of the Patent Co-operation Treaty (PCT) to secure international patent protection for its Asepticsure™ technology. The international patent application consolidates the two previously filed patent applications titled "Healthcare Facility Disinfecting System" and "Disinfecting Process and Apparatus."

8 Jul 2010

Zanett closes $20.6M in new contracts for second-quarter 2010

Zanett, Inc. announced today that Q-2 2010 was a record quarter for the firm with respect to the rate of contracts closed in a quarterly period. Between the period of April 1, 2010 and June 30, 2010, over $20.6 million in new business has been closed. This amount is comprised of 50 different customers, with the largest customer being responsible for a $7.5 million mandate previously announced.

8 Jul 2010

York University study shows misoprostol prevents cell communication

A York University study has shown for the first time how the drug misoprostol, which has been linked to neurodevelopmental defects associated with autism, interferes with neuronal cell function.

8 Jul 2010

OCR, DSHS announce agreement to provide protective services to children in Washington State

The Office for Civil Rights at HHS today announced an agreement to help ensure that children in Washington State in need of welfare and protective services will not be segregated based on race, color, or national origin. OCR, along with the Washington State Department of Social and Health Services and HHS' Administration for Children and Families, signed the voluntary resolution agreement to provide equal access to care needed by one of Washington's more vulnerable populations.

8 Jul 2010

Affymetrix anticipates second-quarter total revenues in the range of $71-72 million

Affymetrix, Inc. today reported that based on preliminary financial data, the Company expects total revenue for the second quarter of 2010 to be in the range of $71-72 million, as compared to the Company's previous guidance in the range of $80-82 million. The company expects product revenue for the second quarter of 2010 to be approximately $65-66 million, including instrument sales of approximately $4-5 million and consumable sales of approximately $60-61 million.

8 Jul 2010

Health information technology improves quality of care, study shows

Secure patient-physician e-mail messaging improves the effectiveness of care for patients with diabetes and hypertension, according to new research by Kaiser Permanente. The study, published in the July issue of Health Affairs, shows that health information technology improves quality of care scores.

8 Jul 2010

Aethlon Medical files provisional patent on behalf of ESI for exosome detection assay

Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that it has filed a provisional patent on behalf of its wholly owned subsidiary Exosome Sciences, Inc. (ESI), relating to the development of an assay that will allow researchers to detect exosomes in blood and other fluids.

8 Jul 2010

New findings show why some people suffer from high levels of triglycerides

New findings reported in the July issue of Cell Metabolism, a Cell Press publication, are offering new leads as to why some people might suffer from high levels of triglycerides. High triglycerides are a risk factor for atherosclerosis and cardiovascular disease. They can also lead to inflammation of the pancreas, the researchers said.

8 Jul 2010

SeqWright becomes first CSP for Agilent SureSelect Target Enrichment System

Agilent Technologies Inc. and SeqWright DNA Technology Services today announced that SeqWright is the first Certified Service Provider for the Agilent SureSelect Target Enrichment System for use with the next-generation AB SOLiD sequencing platform.

8 Jul 2010

Oragenics enters into Common Stock Purchase Agreement with KFLP

On July 5, 2010, Oragenics, Inc. entered into a Common Stock Purchase Agreement with the Koski Family Limited Partnership ("KFLP"), an accredited investor and the Company's largest shareholder. The entering into of the Agreement was approved by the Company's disinterested directors.

8 Jul 2010

HHS awards $390.5M to strengthen medical surge capability in hospitals and health care organizations

States, territories, and large metropolitan areas will receive grants totaling $390.5 million this month to help hospitals and other health care organizations strengthen the medical surge capability across the nation.

8 Jul 2010

Researchers evaluate safety and feasibility of STARR procedure for ODS

Obstructed defecation syndrome represents a widespread clinical problem which frequently affects middle-aged females. Nevertheless, many of the previously established techniques are unsuitable for patients with ODS associated with simultaneous rectocele and rectal intussusception. Notably, STARR has been proposed as an alternative operation and a relatively noninvasive surgical technique for this difficult problem.

8 Jul 2010

Patented computer invention to improve patient security and privacy

A computer security invention patented a decade ago at the National Institute of Standards and Technology (NIST) is now poised to help safeguard patient privacy in hospitals.

8 Jul 2010

Researchers develop computer program to accurately simulate protein folding

All proteins self-assemble in a fraction of the blink of an eye, but it can take a long time to mimic the process. And there has been no guarantee of success, even with the most powerful computers - until now.

8 Jul 2010

Study reveals X+ allele of APOB gene as another risk factor of gallstone formation after gastrectomy

The cause of higher incidence of gallstone after radical gastrectomy still remains unknown. Almost all previous studies have attributed gallstone formation to gallbladder motility disorder after gastrectomy, But this theory cannot completely explain it. Is there any other risk factor of gallstone formation after gastrectomy?

8 Jul 2010

Pfizer invests $100M to expand Singapore Nutrition Plant

Pfizer Inc. today announced a $100 million (U.S.) investment into the expansion of its Singapore Nutrition Plant, helping it continue to set the standard for the manufacture of high-quality, safe and environmentally sustainable nutritional products for infants and children. This expansion, which brings the total investment in the plant to $372 million (U.S.), makes it one of the largest nutritional plants worldwide.

8 Jul 2010

HHS awards $10M to support public health efforts for reducing tobacco use and obesity

The U.S. Department of Health and Human Services (HHS) today announced awards of $10 million to 10 national non-profit organizations to support public health efforts to reduce tobacco use and reduce obesity through increased physical activity and improved nutrition.

8 Jul 2010

Omni Health Media announces launch of CancerConnect.com

Omni Health Media, one of the world's leading specialty publishers of health-related information, websites, applications, and educational programs for individuals with cancer and their caregivers announces the successful launch of CancerConnect.com during the Allen Media Conference in Sun Valley, ID. Cancer Connect is a new social network that will allow people with cancer and those who care for them to share information, inspiration, hope, and support.

8 Jul 2010

TB Alliance, DNDi announce inter-PDP agreement to develop potential anti-TB compounds

The Global Alliance for TB Drug Development and Drugs for Neglected Diseases initiative announced today a unique first-ever royalty-free license agreement between two not-for-profit drug developers that speeds progress toward markedly improved therapy of multiple neglected diseases. The TB Alliance has granted rights to DNDi to develop a class of potential anti-TB compounds that also show significant promise for treating other neglected diseases that largely affect the world's poor.

8 Jul 2010